ID   sHPT-1
AC   CVCL_0I22
DR   Wikidata; Q54953393
RX   PubMed=17126301;
RX   PubMed=26973719;
CC   Doubling time: ~72 hours (PubMed=17126301).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
DI   NCIt; C3630; Benign parathyroid gland neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
CH   CVCL_A8V1 ! sHPT-1/TET1
//
RX   PubMed=17126301; DOI=10.1016/j.bbrc.2006.11.056;
RA   Bjorklund, Peyman
RA   Akerstrom, Goran
RA   Westin, Gunnar
RT   "Activated beta-catenin in the novel human parathyroid tumor cell line
RT   sHPT-1.";
RL   Biochem. Biophys. Res. Commun. 352:532-536(2007).
//
RX   PubMed=26973719; DOI=10.1186/s13148-016-0197-2; PMCID=PMC4789293;
RA   Barazeghi, Elham
RA   Gill, Anthony James
RA   Sidhu, Stan
RA   Norlen, Olov
RA   Dina, Roberto
RA   Palazzo, F. Fausto
RA   Hellman, Per
RA   Stalberg, Peter
RA   Westin, Gunnar
RT   "5-hydroxymethylcytosine discriminates between parathyroid adenoma and
RT   carcinoma.";
RL   Clin. Epigenetics 8:31.1-31.11(2016).
//